Related Experiment Video
Updated: Aug 13, 2025

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Identification of BMP10 as a Novel Gene Contributing to Dilated Cardiomyopathy
Jia-Ning Gu1, Chen-Xi Yang1, Yuan-Yuan Ding2
1Department of Cardiology, Shanghai Fifth People's Hospital, Fudan University, Shanghai 200240, China.
Insights
Researchers identified a new gene, BMP10, linked to dilated cardiomyopathy (DCM), a common heart muscle disease. This discovery offers potential for earlier genetic diagnosis and targeted prevention strategies for DCM patients.
Area of Science:
- Cardiology
- Genetics
- Molecular Biology
Background:
- Dilated cardiomyopathy (DCM) is a prevalent cardiac muscle disease causing heart failure and requiring heart transplantation.
- While genetic factors are implicated, many DCM-causing genes remain undiscovered, necessitating further research.
- Understanding the genetic basis of DCM is crucial for diagnosis and treatment.
Purpose of the Study:
- To identify novel genetic causes of dilated cardiomyopathy (DCM).
- To investigate the role of the BMP10 gene in autosomal-dominant DCM within a Chinese Han family.
- To elucidate the functional consequences of a novel BMP10 variant on gene regulation.
Main Methods:
- Whole-exome sequencing and Sanger sequencing were employed to analyze DNA from affected family members.
- A novel BMP10 variant (c.166C > T; p.(Gln56*)) was identified and its co-segregation with DCM phenotype was confirmed.
- Dual-luciferase reporter assays were performed to assess the functional impact of the mutant BMP10 on target gene transactivation.
Main Results:
- A novel heterozygous BMP10 variant, p.(Gln56*), was found to segregate with DCM in a multigenerational Chinese Han family.
- This BMP10 variant was absent in 268 healthy control subjects.
- The Gln56*-mutant BMP10 demonstrated impaired transactivation of known DCM-related genes, NKX2.5 and TBX20.
Conclusions:
- BMP10 is identified as a novel causative gene for dilated cardiomyopathy in humans.
- BMP10 haploinsufficiency emerges as a potential pathogenic mechanism in DCM.
- These findings may facilitate early genetic diagnosis and precision prophylaxis of DCM.
Abstract:
Dilated cardiomyopathy (DCM), characterized by left ventricular or biventricular enlargement with systolic dysfunction, is the most common type of cardiac muscle disease. It is a major cause of congestive heart failure and the most frequent indication for heart transplantation. Aggregating evidence has convincingly demonstrated that DCM has an underlying genetic basis, though the genetic defects responsible for DCM in a larger proportion of cases remain elusive, motivating the ongoing research for new DCM-causative genes. In the current investigation, a multigenerational family affected with autosomal-dominant DCM was recruited from the Chinese Han population. By whole-exome sequencing and Sanger sequencing analyses of the DNAs from the family members, a new BMP10 variation, NM_014482.3:c.166C > T;p.(Gln56*), was discovered and verified to be in co-segregation with the DCM phenotype in the entire family. The heterozygous BMP10 variant was not detected in 268 healthy volunteers enrolled as control subjects. The functional measurement via dual-luciferase reporter assay revealed that Gln56*-mutant BMP10 lost the ability to transactivate its target genes NKX2.5 and TBX20, two genes that had been causally linked to DCM. The findings strongly indicate BMP10 as a new gene contributing to DCM in humans and support BMP10 haploinsufficiency as an alternative pathogenic mechanism underpinning DCM, implying potential implications for the early genetic diagnosis and precision prophylaxis of DCM.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy V: Interprofessional Care
Incomplete Dominance
Animal Mitochondrial Genetics

